We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

189 hedge funds and large institutions have $2.01B invested in Agios Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 73 increasing their positions, 54 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 54

2.01% more ownership

Funds ownership: 103.34% → 105.35% (+2%)

3% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 31

0% more funds holding

Funds holding: 189 → 189 (0)

34% less capital invested

Capital invested by funds: $3.03B → $2.01B (-$1.02B)

75% less call options, than puts

Call options by funds: $8.62M | Put options by funds: $35.1M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
189
Holders Change
–
Holders Change %
0%
% of All Funds
4.14%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
73
Reduced
54
Closed
31
Calls
$8.62M
Puts
$35.1M
Net Calls
-$26.5M
Net Calls Change
-$32.3M

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$56.8M
2
Macquarie Group
Macquarie Group
Australia
+$34.9M
3
BG
Bellevue Group
Switzerland
+$18.4M
4
CC
Casdin Capital
New York
+$18.2M
5
CII
Capital International Inc
California
+$13.1M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$60M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$23.9M
3
First Trust Advisors
First Trust Advisors
Illinois
-$20.5M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
-$14.8M
5
Citadel Advisors
Citadel Advisors
Florida
-$11.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$4.66M +$2.68M +64,720 +82%
TCM
52
Tekla Capital Management
Massachusetts
$4.61M -$129K -3,125 -2%
Renaissance Technologies
53
Renaissance Technologies
New York
$3.92M +$2.93M +70,700 +141%
AA
54
ALPS Advisors
Colorado
$3.8M -$219K -5,286 -4%
ZIC
55
ZWJ Investment Counsel
Georgia
$3.77M +$1.29M +31,180 +37%
Rafferty Asset Management
56
Rafferty Asset Management
New York
$3.76M +$1.06M +25,678 +28%
CM
57
Caption Management
Oklahoma
$3.71M +$4.74M +114,600 New
Two Sigma Investments
58
Two Sigma Investments
New York
$3.67M +$2.31M +55,866 +97%
Wells Fargo
59
Wells Fargo
California
$3.6M -$204K -4,920 -4%
SGA
60
Sector Gamma AS
Norway
$3.33M – – –
Swiss National Bank
61
Swiss National Bank
Switzerland
$3.22M +$70.4K +1,700 +2%
PI
62
Putnam Investments
Massachusetts
$3.16M +$4.04M +97,500 New
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$2.8M +$1.04M +25,100 +41%
State Board of Administration of Florida Retirement System
64
State Board of Administration of Florida Retirement System
Florida
$2.77M +$18.2K +440 +0.5%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$2.67M +$12.5K +302 +0.4%
Alyeska Investment Group
66
Alyeska Investment Group
Illinois
$2.55M -$5.5M -132,868 -63%
Citigroup
67
Citigroup
New York
$2.54M +$1.55M +37,552 +92%
EVM
68
Eaton Vance Management
Massachusetts
$2.43M -$2.44M -58,879 -44%
PP
69
PDT Partners
New York
$2.37M -$869 -21 -0%
Marshall Wace
70
Marshall Wace
United Kingdom
$2.31M +$2.95M +71,260 New
Neuberger Berman Group
71
Neuberger Berman Group
New York
$2.16M -$1.01M -24,440 -27%
PAMU
72
Pictet Asset Management (UK)
United Kingdom
$1.89M -$14.8M -358,464 -86%
OC
73
Oppenheimer & Co
New York
$1.88M – – –
CSS
74
Cubist Systematic Strategies
Connecticut
$1.87M +$1.57M +38,039 +194%
UBS Group
75
UBS Group
Switzerland
$1.83M +$2.1M +50,819 +904%
1 2
3
4 5

AGIO Hedge Fund Activity: Q3 2019 in Review

189 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q3 2019, worth a combined $2.01B — down 34% from $3.03B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new AGIO positions and 31 closed out — a net gain of 1 holder — while 73 added to existing stakes and 54 trimmed.

The largest buyer was Capital International Investors, adding an estimated $56.8M. The largest seller was BlackRock, cutting an estimated $60M.

  • 189 institutional investors held Agios Pharmaceuticals (AGIO) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $2.01B of Agios Pharmaceuticals stock for Q3 2019, down 34% quarter-over-quarter.
  • 32 funds opened new Agios Pharmaceuticals positions in Q3 2019 and 31 closed out, a net change of +1 holder.
  • The largest Agios Pharmaceuticals buyer in Q3 2019 was Capital International Investors, an estimated $56.8M added.
  • The largest Agios Pharmaceuticals seller in Q3 2019 was BlackRock, an estimated $60M sold.

Based on aggregated 13F filings for Q3 2019.